vs
KKR Real Estate Finance Trust Inc.（KREF）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
KKR Real Estate Finance Trust Inc.的季度营收约是TriSalus Life Sciences, Inc.的2.0倍（$25.8M vs $13.2M），TriSalus Life Sciences, Inc.净利率更高（-73.9% vs -101.7%，领先27.9%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs -26.6%），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs -18.8%）
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
KREF vs TLSI — 直观对比
营收规模更大
KREF
是对方的2.0倍
$13.2M
营收增速更快
TLSI
高出86.4%
-26.6%
净利率更高
TLSI
高出27.9%
-101.7%
两年增速更快
TLSI
近两年复合增速
-18.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.8M | $13.2M |
| 净利润 | $-26.2M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | -105.1% | -24.8% |
| 净利率 | -101.7% | -73.9% |
| 营收同比 | -26.6% | 59.8% |
| 净利润同比 | -229.6% | 3.5% |
| 每股收益（稀释后） | $-0.49 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KREFTLSI
| Q4 25 | $25.8M | $13.2M | ||
| Q3 25 | $25.3M | $11.6M | ||
| Q2 25 | $30.2M | $11.2M | ||
| Q1 25 | $31.3M | $9.2M | ||
| Q4 24 | $35.1M | $8.3M | ||
| Q3 24 | $37.0M | $7.3M | ||
| Q2 24 | $40.4M | $7.4M | ||
| Q1 24 | $39.1M | $6.5M |
净利润KREFTLSI
| Q4 25 | $-26.2M | $-9.8M | ||
| Q3 25 | $13.8M | $-10.8M | ||
| Q2 25 | $-29.7M | $-8.3M | ||
| Q1 25 | $-4.9M | $-10.4M | ||
| Q4 24 | $20.3M | $-10.1M | ||
| Q3 24 | $-7.4M | $-2.4M | ||
| Q2 24 | $25.8M | $-4.3M | ||
| Q1 24 | $-3.1M | $-13.2M |
毛利率KREFTLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率KREFTLSI
| Q4 25 | -105.1% | -24.8% | ||
| Q3 25 | 50.4% | -77.9% | ||
| Q2 25 | -101.3% | -65.4% | ||
| Q1 25 | -18.3% | -79.9% | ||
| Q4 24 | 55.8% | -91.8% | ||
| Q3 24 | -19.6% | -118.9% | ||
| Q2 24 | 63.3% | -111.0% | ||
| Q1 24 | -8.7% | -180.8% |
净利率KREFTLSI
| Q4 25 | -101.7% | -73.9% | ||
| Q3 25 | 54.4% | -93.5% | ||
| Q2 25 | -98.5% | -73.9% | ||
| Q1 25 | -15.5% | -113.2% | ||
| Q4 24 | 57.7% | -122.4% | ||
| Q3 24 | -20.0% | -32.6% | ||
| Q2 24 | 63.9% | -58.8% | ||
| Q1 24 | -7.9% | -204.5% |
每股收益（稀释后）KREFTLSI
| Q4 25 | $-0.49 | $-0.22 | ||
| Q3 25 | $0.12 | $-0.96 | ||
| Q2 25 | $-0.53 | $-0.27 | ||
| Q1 25 | $-0.15 | $-0.39 | ||
| Q4 24 | $0.22 | $-0.38 | ||
| Q3 24 | $-0.19 | $-0.12 | ||
| Q2 24 | $0.29 | $-0.21 | ||
| Q1 24 | $-0.13 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.6M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $-33.9M |
| 总资产 | $6.5B | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KREFTLSI
| Q4 25 | $84.6M | $20.4M | ||
| Q3 25 | $204.1M | $22.7M | ||
| Q2 25 | $107.7M | $26.5M | ||
| Q1 25 | $106.4M | $13.0M | ||
| Q4 24 | $104.9M | $8.5M | ||
| Q3 24 | $108.8M | $11.3M | ||
| Q2 24 | $107.2M | $16.5M | ||
| Q1 24 | $106.5M | $4.0M |
股东权益KREFTLSI
| Q4 25 | $1.2B | $-33.9M | ||
| Q3 25 | $1.2B | $-26.7M | ||
| Q2 25 | $1.2B | $-19.4M | ||
| Q1 25 | $1.3B | $-34.4M | ||
| Q4 24 | $1.3B | $-25.9M | ||
| Q3 24 | $1.4B | $-20.4M | ||
| Q2 24 | $1.4B | $-25.3M | ||
| Q1 24 | $1.4B | $-36.0M |
总资产KREFTLSI
| Q4 25 | $6.5B | $35.3M | ||
| Q3 25 | $6.5B | $36.5M | ||
| Q2 25 | $6.8B | $41.3M | ||
| Q1 25 | $6.6B | $28.6M | ||
| Q4 24 | $6.4B | $24.0M | ||
| Q3 24 | $6.8B | $27.5M | ||
| Q2 24 | $7.1B | $32.4M | ||
| Q1 24 | $7.3B | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $72.3M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势，按日历期对齐
经营现金流KREFTLSI
| Q4 25 | $72.3M | $-2.5M | ||
| Q3 25 | $18.5M | $-3.7M | ||
| Q2 25 | $21.1M | $-7.3M | ||
| Q1 25 | $15.9M | $-4.5M | ||
| Q4 24 | $132.6M | $-5.7M | ||
| Q3 24 | $49.1M | $-10.8M | ||
| Q2 24 | $30.6M | $-13.4M | ||
| Q1 24 | $34.5M | $-10.9M |
自由现金流KREFTLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
自由现金流率KREFTLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
资本支出强度KREFTLSI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
现金转化率KREFTLSI
| Q4 25 | — | — | ||
| Q3 25 | 1.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.54× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
